Font Sizes: A A A


Cooperative European Medicines Development Course

Fourth CEMDC Course 2017-2019

For current and future pharma managers from all countries

The 4th CEMDC course has started in Budapest in October 2017. – The aim of the course is to train experts who understand the complex process of medicines development from molecule to health care and who can apply this knowledge working in large or small, innovative or generic pharmaceutical companies, regulatory agencies, in health care and health research or insurance management. The course material was carefully compiled by academic and industry experts to meet the needs of both the pharmaceutical industry and health care. It covers the 3 main competency areas of medicines development: Drug Development and Clinical Trials; Regulatory Affairs and Safety of Medicines; Health Care and Professionalism. The teaching follows the international, harmonized modular training program and quality standards developed by PharmaTrain. The CEMDC is internationally accredited as a PharmaTrain Center of Excellence. The entire Base Diploma Course contains 8 modules. Certain modules might be presented at other participating universities. Each module lasts 4 days and is finished by an examination. The modules are given in 2-3 month intervals. It is possible to visit only selected modules to satisfy individual educational needs. Students can apply with medical, pharmaceutical, MSc or equivalent degrees in natural and life sciences. The course is open for students of all nationalities.  The official language of the course is English. Coordinated by the Semmelweis University, Budapest, Hungary. Participation fee

  • 800 EUR per module if the entire course is registered
  • 1000 EUR per module if certain module(s) is (are) registered
  • Final exam: 500 EUR

Application Form

General Description of the Course

Learn medicines development from molecule to patients at a PharmaTrain accredited international course organized jointly by 10 regional universities

The course is open for students from all countries.

The need to provide high-quality and cost-effective medication for mankind living in various countries led to the intensive globalization of the research and manufacturing of medicines. The global need for properly educated professionals with a broad education covering all aspects of medicine development can be primarily provided by highly complex life-long continuous professional training. Unfortunately, countries with smaller populations and/or small size pharmaceutical industry cannot provide and maintain this education cost-effectively for a prolonged time. For covering their needs the Cooperative European Medicines Development Course (CEMDC) was organized with the participation of 10 regional universities. The PharmaTrain harmonized European course program is used for the teaching.  

PharmaTrain, the European harmonized concept of teaching medicines development

The aim of the course scientifically accredited by PharmaTrain and IFAPP is to train experts who understand the complex process of medicines development from molecule to health care and who can apply this knowledge working in large or small, innovative or generic pharmaceutical companies, enterprises, regulatory agencies in health care and health insurance management. The course material was carefully compiled by academic and industry experts to meet the needs of both the pharmaceutical industry and health care. Who should apply? The target student population is composed of professionals with medical, pharmaceutical, MSc or equivalent degrees in natural and life sciences. Suitable applicants will be accepted from any country. An adequate knowledge of English is necessary in order to follow the lectures, participate in the discussions and complete the various forms of assessments. For admission, students must submit a copy of their degrees, a certificate or any other document proving their knowledge of English, and a CV describing their professional experience if available.

Modules can be visited also individually according to personal training needs. It is suggested that all Base Course modules should be completed together. Individual selection of advanced elective modules is primarily recommended to collect credits for a continuous individual professional development program and/or for obtaining a master level degree.

Structure of the CEMDC education program The Base Course contains 8 modules which provide a complete overview of all drug development related topics listed in the PharmaTrain Syllabus. The 6 consecutive mandatory basic modules are finished by an integrated assessment evaluated centrally according to PharmaTrain harmonized criteria. Following a successful examination the students receive a Diploma in Medicines Development. The overall learning outcome: at the end of the Base Course the students should be able to understand and apply the basic principles of medicines development science in their working practice. The PharmaTrain accredited Base Course modules are presented uniformly by each PharmaTrain associated centers. Advanced elective modules: in addition to the Base Course, the CEMDC and also the other PharmaTrain course providers offer PharmaTrain accredited elective modules offering a more detailed knowledge and competence in various fields of medicines development. These advanced modules can be freely selected according to individual professional needs. Each basic and advanced elective module will be evaluated separately permitting the transfer of credits between PharmaTrain accredited courses. The modular teaching concept: each module has several PharmaTrain defined learning outcomes which have to be fulfilled uniformly by each course provider. The completion of each module requires 25-30 hours of face-to-face sessions delivered within 4 days every third month. At these meetings the students listen to review lectures, participate in case discussions and tutorial workshops. The direct contact teaching is preceded by extensive home learning of E-modules and selected materials as well as preparatory reading for the team works at the joint sessions. The multiple choice question (MCQ) examination at the end of each module is primarily based on the home learning. In addition, following the face-to-face meeting the students have to submit 1 or 2 assignments consisting of 1200 words. The final note of a module will be based on the joint evaluation of the MCQ examination and the assignments. A failed MCQ examination session can be repeated at the time of the next module. Base Course Modules


Organization and location of the modules. All educational activities will be carried out in English. The students will be organized into a single international group and will be taught at the same location at the same time. The face-to-face teaching sessions of the various modules may be held at different locations in various participating countries. The international teaching faculty will be selected from academic, industrial and regulatory experts working primarily in Europe. The participation of teachers working in the region will be especially encouraged. Download: SOP3 CEMDC_Version 3, Student Information_ 20130330 Advanced Course Modules PharmaTrain accredited elective modules presented by various PharmaTrain associated course providers. A steadily growing number of advanced elective modules will be presented by the various course providers at different time points. These modules offer more detailed additional information compared to the base modules on specific drug development issues. Some modules might be taught by several courses or presented in cooperation by PharmaTrain accredited partners. For additional information please consult the PharmaTrain website  and/or the PharmaTrain section of the CEMDC website.  Elective modules to be presented by the CEMDC

  • Biologicals and advanced therapies
  • Generic and biosimilar medicinal products
  • Special populations; clinical trial practice and regulation

Tuition fee The CEMDC is a non-profit organization. The participation fee will primarily cover the traveling and local accommodation costs of the international lecturers.The tuition fee will be defined separately for each course. The participation fee should be paid in two parts according to agreement.  In addition, the students have to pay their travel and local accommodation expenses. (The organizers will try to make special arrangements for affordable lodging during the modules). Please note that the price is mainly determined by the travel and accommodation expenses of the international team of lecturers. According to international experience, many pharmaceutical companies and other organizations might offer financial support for their employees to visit such courses. In some cases, primarily for students working in non-profit organizations a reduction of the tuition fee might be granted by the Governing Board of the CEMDC. In general, the Basic Course will be provided every second year. Advanced elective modules will be presented parallel with the Basic Course but at different dates not interfering with the presentation of the basic modules.

Fitting the needs of health care and the pharmaceutical industry

In close cooperation with experts from various fields, PharmaTrain has established 180 teaching topics along the road from molecule to the market place. This comprehensive Syllabus of Medicines Development is mapped to 60 Learning Outcomes representing the requirements of the society.

Trainee’s competence profile

The PharmaTrain Syllabus/Learning Outcomes’ approach allows profiling the competences of employees and professional trainees, respectively. Comparing the actual versus a target profile reveals deficits that can be filled by taking PharmaTrain recognised training modules.

International acceptance

Thanks to the international organisation of the program and its connection with the PharmaTrain harmonised training project the CEMDC can guarantee the favourable recognition of its diploma at the international level.

Standard Operation Procedure CEMDC Student Information

Download: SOP3 CEMDC_Version 3, Student Information_ 20130330

PharmaTrain Syllabus

Download: PharmaTrain Syllabus_V013_Clean_2010


All the CEMDC related activities are coordinated by the Semmelweis University, Budapest, Hungary.

CEMDC Cooperative European Medicines Development Course Semmelweis University, Department of Pharmacology and Pharmacotherapy
Nagyvárad tér 4. H-1089 Budapest, Hungary

Study Director:
Dr. S. Kerpel-Fronius